Diaceutics (LON:DXRX) Trading Down 4.4% – Time to Sell?

Diaceutics PLC (LON:DXRX) traded down 4.4% during trading on Friday . The stock traded as low as GBX 150 and last traded at GBX 151. 74,272 shares traded hands during trading, a decline of 47% from the average session volume of 139,853 shares. The stock had previously closed at GBX 158.

Diaceutics Stock Performance

The stock’s 50-day simple moving average is GBX 161.87 and its 200 day simple moving average is GBX 141.97. The company has a market capitalization of £127.78 million, a PE ratio of -83.89 and a beta of 0.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85.

Diaceutics (LON:DXRX) last issued its earnings results on Tuesday, September 23rd. The company reported GBX (2.84) EPS for the quarter. Diaceutics had a negative return on equity of 7.15% and a negative net margin of 10.90%. As a group, research analysts expect that Diaceutics PLC will post 1.0107919 earnings per share for the current fiscal year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.